Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MacroGenics, Inc. - Common Stock
(NQ:
MGNX
)
2.200
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MacroGenics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
April 03, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
March 08, 2024
MGNX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023
March 07, 2024
MGNX stock results show that Macrogenics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 07, 2024
Via
Benzinga
Macrogenics: Q4 Earnings Insights
March 07, 2024
Via
Benzinga
A Preview Of Macrogenics's Earnings
March 06, 2024
Via
Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 3/5
March 05, 2024
Via
Investor Brand Network
Analyst Expectations For Macrogenics's Future
March 04, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Decoding 4 Analyst Evaluations For Macrogenics
February 14, 2024
Via
Benzinga
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
March 04, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/12
February 12, 2024
Via
Investor Brand Network
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/6
February 06, 2024
Via
Investor Brand Network
MicroMarvel MacroGenics Confuses Wall Street
February 05, 2024
100% technical buy signals. 15 new highs and up 66.53% last month. 280.00+ Weighted Alpha
Via
Talk Markets
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/1
February 01, 2024
Via
Investor Brand Network
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Demystifying Macrogenics: Insights From 5 Analyst Reviews
January 24, 2024
Via
Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 1/23
January 23, 2024
Via
Investor Brand Network
Forecasting The Future: 4 Analyst Projections For Macrogenics
December 20, 2023
Via
Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The 3 Most Undervalued Biotech Stocks to Buy in January
January 15, 2024
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.
Via
InvestorPlace
MacroGenics to Participate in Upcoming Investor Conference
January 08, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.
Via
Benzinga
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
December 20, 2023
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Top 4 Health Care Stocks That May Crash This Month
December 20, 2023
As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
December 20, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.